Cancer Institute and Hospital, Chinese Academy of Medical Sciences clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 387 studies whose lead sponsor is Cancer Institute and Hospital, Chinese Academy of Medical Sciences. 275 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Cancer Institute and Hospital, Chinese Academy of Medical Sciences studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Where
- China
- 330
Focus areas
Conditions Cancer Institute and Hospital, Chinese Academy of Medical Sciences leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 387. Browse all 387 →
- The QL1706 Combined With Chemotherapy and Either Cetuximab or Bevacizumab in Potentially Resectable Colorectal Cancer Patients With Liver MetastasesNot yet recruitingNCT07863869Phase 1/2
- The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral CrisisRecruitingNCT07203729Phase 2
- SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLCRecruitingNCT06457906Phase 3
- Clinical Study of Three-dimensional Lattice Radiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Advanced Solid TumorsRecruitingNCT07865793Phase 2
- Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell CarcinomaRecruitingNCT06342167Phase 2
- Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive LymphomaRecruitingNCT07657494Not applicable
- Phase I Study of In Vivo CAR-Tumor Technology for the Treatment of Advanced Malignant TumorsNot yet recruitingNCT07859462Phase 1
- Radiotherapy Target Volume Delineation in Locally Advanced Esophageal Cancer in the Immunotherapy EraRecruitingNCT07858630
- Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI ResistanceNot yet recruitingNCT07842887Phase 1
- Rimegepant Plus Toripalimab in Advanced Urothelial Carcinoma After Failure of Standard TherapyRecruitingNCT07835035Phase 1
- Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)RecruitingNCT06146946Not applicable
- Video-Assisted Thoracoscopic Surgery Combined With Radiofrequency Ablation Versus VATS Alone for Multiple Primary Lung CancerNot yet recruitingNCT07819669Not applicable
- A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular CarcinomaRecruitingNCT07557251Phase 1
- A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory LymphomaNot yet recruitingNCT07791615Phase 2
- YSCH-01 Via Nebulization in Pulmonary Metastasis of Advanced Solid Tumors and Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07793500Early Phase 1
- Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC StudyRecruitingNCT07773818
- Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast CancerRecruitingNCT06993506
- Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer(UPGRADE-TNBC)Enrolling by invitationNCT06910072Phase 2/3
- COLORS-Validate Study of Decision-Support Software for Surgical Sequencing in Colorectal Liver MetastasesNot yet recruitingNCT07760558
- SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular CarcinomaNot yet recruitingNCT07749859Phase 2
- An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal TumorsRecruitingNCT07743749
- Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ AdenocarcinomaRecruitingNCT06417892
- Multimodal Ablation Combined With Perioperative Tislelizumab and Chemotherapy for Resectable II-IIIB NSCLCNot yet recruitingNCT07729670Phase 2
- An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine TumorsRecruitingNCT06038461Phase 1/2
- Fruquintinib Plus Anti-EGFR Antibody for Third-Line Treatment of RAS Wild-Type mCRCRecruitingNCT07724223Phase 2
- Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label StudyEnrolling by invitationNCT07373899
- Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell CarcinomaRecruitingNCT07692152Phase 3
- Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric CancerRecruitingNCT07689851Phase 2
- A Phase II Study of Radiation Therapy to Treat Refractory Breast CancerNot yet recruitingNCT07672743Not applicable
- Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor PatientsRecruitingNCT07366658Phase 1
- Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC ImmunotherapyRecruitingNCT07668037
- Efficacy and Safety of Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma: A Multicenter Prospective Phase II StudyRecruitingNCT07636824Phase 2
- Hypofractionated vs Conventional RT After Prosthetic Breast ReconstructionRecruitingNCT07084519Phase 3
- Inhaled mRNA Immunotherapy for Patients With Advanced Lung Cancer or Pulmonary Metastatic Solid TumorsNot yet recruitingNCT07657611Early Phase 1
- Risk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast CancerNot yet recruitingNCT07657442Not applicable
- QH101 Cell Injection in Patients With Brain, Brain (Spinal) Meninges, and Spinal Cord Metastatic Malignant Solid TumorsNot yet recruitingNCT07656103Early Phase 1
- Prospective Randomized Controlled Clinical Study of Acupoint Application With Gutong Plaster in the Treatment of Moderate to Severe Cancer PainRecruitingNCT07657390Phase 1/2
- Safety and Efficacy of Intravenous IDOV-Immune in Patients With Advanced Solid TumorsEnrolling by invitationNCT07656090Early Phase 1
- CONNEctome-guided Navigation for Eloquent-area Tumor Surgery TrialRecruitingNCT07657403Not applicable
- CIB In Vivo CAR-T Lentiviral Injection in Patients With Advanced Malignant TumorsNot yet recruitingNCT07657585Phase 1
- Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant TumorsRecruitingNCT07656116Phase 1
- OVV-01 Intravenous and Intratumoral Injection Combined With AK112 for the Treatment of Advanced Solid TumorsNot yet recruitingNCT07650825Phase 1
- The Application of Symptoms Management Program Based on the Patient Reported Outcome After EsophagectomyRecruitingNCT07187154Not applicable
- OVV-01 Injection Combined With AK112 Injection for the Treatment of Patients With Advanced Soft Tissue Sarcoma (STS)Not yet recruitingNCT07650838Phase 2
- Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.RecruitingNCT06771609Phase 2
- Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain MetastasisRecruitingNCT06839560Phase 2
- A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug as a Radiosensitizer in Patients With Advanced Breast Cancer Brain Metastasis.RecruitingNCT06839547
- Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast CancerRecruitingNCT06908668Phase 2
- A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast CancerRecruitingNCT06776861
- Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND)Not yet recruitingNCT07306390